← Back to Search

Behavioral Intervention

Reminder Notices for Papillomavirus Vaccines

N/A

Waitlist Available

Research Sponsored by Huong McLean, PhD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial will study whether sending reminders for the HPV vaccine to parents' preferred method of communication will increase HPV vaccination rates among 12 year-olds in rural areas.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of patients that received 1 dose of HPV vaccine during follow-up based on electronic health data

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard of CareExperimental Treatment1 Intervention

Group II: Enhanced ReminderExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Huong McLean, PhDLead Sponsor

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,471,951 Total Patients Enrolled

Media Library

Reminder Sent Via Preferred Method of Communication (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05148559 — N/A

Papillomavirus Vaccines Research Study Groups: Enhanced Reminder, Standard of Care

Papillomavirus Vaccines Clinical Trial 2023: Reminder Sent Via Preferred Method of Communication Highlights & Side Effects. Trial Name: NCT05148559 — N/A

Reminder Sent Via Preferred Method of Communication (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05148559 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I a viable candidate for this clinical experiment?

"To qualify for this study, applicants must have prior vaccinations against papillomavirus and be aged between 12-25. Altogether there is a recruitment target of 2500 participants."

Answered by AI

Does the research encompass individuals aged 70 years and over?

"This medical trial is limited to those between the ages of 12 and 65. Additionally, there are separate studies available for individuals below age 18, as well as a specialised study designed specifically for patients above the century mark."

Answered by AI

Is this research endeavor recruiting new participants?

"As evidenced on clinicaltrials.gov, this particular medical trial is not presently recruiting participants. It was first posted on August 12th 2021 and was last updated October 6th 2022. Despite being closed to new admissions, there are 4 other trials open for enrollment at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

Huong McLean, PhD 2021. "Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05148559.